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Abstract
Fibroblasts and their activated phenotype, myofibroblasts, are the primary cell types involved in
the contraction associated with dermal wound healing. Recent experimental evidence indicates
that the transformation from fibroblasts to myofibroblasts involves two distinct processes: the
cells are stimulated to change phenotype by the combined actions of transforming growth factor
β (TGFβ) and mechanical tension. This observation indicates a need for a detailed exploration
of the effect of the strong interactions between the mechanical changes and growth factors in
dermal wound healing. We review the experimental findings in detail and develop a model of
dermal wound healing that incorporates these phenomena. Our model includes the interactions
between TGFβ and collagenase, providing a more biologically realistic form for the growth factor
kinetics than those included in previous mechanochemical descriptions. A comparison is made
between the model predictions and experimental data on human dermal wound healing and all
the essential features are well matched.
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1. Introduction
The process of dermal repair is intricate and the resulting scar is inferior to unwounded tissue
in several aspects. Aberrant healing may result in pathological scarring that can cause both
physical and psychosocial distress to the patient (Herber et al., 2007; Brown et al., 2008, 2010).
Understanding and elucidating the mechanisms that elicit normal and regenerative repair is vital
to ameliorating the wound healing response.
There are various ways of characterizing the stages of acute healing. A recent description pro-
posed by Enoch et al. (2006) separates wound healing into four overlapping, yet distinct, phases.
The first one: (1) haemostasis, which involves arresting blood flow through the establishment of
a fibrin clot (Monroe et al., 2010) and (2) inflammation, where neutrophils, macrophages and
other leukocytes debride the wound, removing necrotic cells and damaged tissue (Enoch and
Leaper, 2007). These cells also release growth factors that attract fibroblasts, the main cell type
in dermal repair, to the wound (Shultz et al., 2005). The other stages are: (3) proliferation and
(4) epithelialisation and remodelling. As the model we describe concerns these final two phases,
we now discuss these stages in more detail.
The proliferative phase begins around day 4 post-wounding when fibroblasts are recruited from
the surrounding undamaged tissue (Shultz et al., 2005). These cells proliferate and are acti-
vated to become myofibroblasts. Both fibroblasts and myofibroblasts function as the primary
contractile cells in wound repair, with myofibroblasts exerting stronger cell traction stresses than
fibroblasts (Wipff and Hinz, 2009). Together, these cells synthesize proteins such as collagen to
replace the fibrin network, and they remodel the resulting collagen lattice (Hinz, 2007). Con-
currently, endothelial cells migrate into the wound space, revascularising the wound in a process
known as angiogenesis (Enoch and Leaper, 2007). The proliferating fibroblasts, loose collagen
network and neovascularised tissue form a temporary contractile organ known as granulation
tissue (Enoch and Leaper, 2007). The contraction of granulation tissue due to the action of fi-
broblasts and myofibroblasts results in a wound reduction of up to 30% in humans (Desmouliere
et al., 1995; Hinz et al., 2001; Farahani and Kloth, 2008) and up to 80% in rats (Farahani and
Kloth, 2008). Finally, the onset of reepithelialisation signals the final phase of proliferation.
In the fourth and final stage of wound healing, the outer epidermal layer is restored. Fibroblasts
continue to remodel the extracellular matrix, increasing the tensile strength of the wound from
approximately 20% to 70% of normal dermal strength after several months of remodelling (Co-
tran et al., 1999; Singer and Clark, 1999). Finally, a mature scar consisting mainly of collagen
develops.
The mathematical literature abounds with investigations into wound repair. Just a sample of
the diverse topics considered include angiogenesis (Pettet et al., 1996; Tranqui and Tracqui,
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2000; Schugart et al., 2008), the interaction between fibroblast and collagen fibre orientation
(Dallon and Sherratt, 1998; Dallon et al., 1999, 2001; McDougall et al., 2006; Cumming et al.,
2010), effects due to growth factors (Dale et al., 1997; Vermolen and Javierre, 2010), simple me-
chanical effects (Tranquillo and Murray, 1992; Tracqui et al., 1995; Murray et al., 1997; Murray,
2003), myofibroblast-enhanced contraction (Olsen et al., 1995, 1996), the interaction between
the collagen lattice and extracellular fluid during contraction (Barocas and Tranquillo, 1997),
the effects of matrix anisotropy (Cook, 1995), abnormal dermal repair (Waugh and Sherratt,
2006; Thackham et al., 2008; Xue et al., 2009; Flegg et al., 2010) and models incorporating
a combination of wound healing phenomena (Javierre et al., 2009; Hall, 2009; Murphy et al.,
2011). However, none of these studies include an explicit description of the mechanical inter-
action between the cells and their viscoelastic substrate of extracellular matrix (ECM) coupled
with a realistic description of the chemical kinetics. We address this issue in the current article.
The first mechanochemical models for dermal wound healing were developed by Murray et al.
(1988) and Tranquillo and Murray (1992). The key feature of these models was the mechanical
interaction between the cells and their viscoelastic substrate of extracellular matrix (ECM). The
“base” Tranquillo-Murray model comprises three governing equations; two of these stipulate the
rate of change of the fibroblast concentration, n, and the ECM density, ρ, respectively, while
the third describes a force balance, from which the velocity of the ECM is derived. In one-
dimensional Cartesian coordinates, the base non-dimensional model takes the following form:
Cells :
∂n
∂t
+
∂
∂x
(
n
∂u
∂t
)
=
∂2n
∂x2
+ rn(1− n); (1)
ECM :
∂ρ
∂t
+
∂
∂x
(
ρ
∂u
∂t
)
= 0; (2)
Force Balance : sρu =
∂
∂x
(
σ + µ
∂v
∂x
+ ψ
)
; (3)
Elastic Force : σ =
∂u
∂x
; (4)
Cell-Traction Force : ψ =
τρn
1 + γn2
; (5)
Velocity : v =
∂u
∂t
; (6)
where x is the distance from the wound centre, u is the ECM displacement, µ is the viscosity
of the tissue, γ is a parameter quantifying “social loafing” (the amount that a species will stop
doing work in the presence of other members of the same species), s is the tethering coefficient
of the dermal layer to the subcutaneous tissue, τ is a measure of the fibroblast traction on ECM
fibres, and r is the intrinsic growth rate of fibroblasts. The model considers a symmetric wound
about x = 0, with the wound located on 0 < x < L, such that 2L is the width of the wound.
The region x > L corresponds to the surrounding unwounded dermis.
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While this seminal model laid the groundwork for much of the subsequent years of research
in this area, it neglected some of the essential features of wound healing, such as collagen
biosynthesis and heightened collagen density in the wound space. Moreover, this model was
unable to describe the significant wound boundary contraction common in dermal repair. While
Tranquillo and Murray (1992) did extend their model to incorporate some of these features, the
limitations of this formulation, together with the wealth of new experimental data means that
a more detailed representation has become a necessity.
One of the key simplifying assumptions made by Tranquillo and Murray (1992) was that alter-
ations to the ECM do not modify the mechanical properties of the tissue. However, experimental
results reveal that this is not the case (Shultz et al., 2005). In the present study, we aim to
improve on this model by assuming, like authors such as Ramtani et al. (2002), that tissue
elasticity is dependent upon the collagen density.
Olsen and co-workers extended the work of Tranquillo-Murray in a series of papers (Olsen et al.,
1995, 1996, 1997, 1998, 1999). Their first advance considered two distinct cellular populations: fi-
broblasts and myofibroblasts. Inter-conversion between the two phenotypes is assumed, and this
is taken to be dependent on the presence of a growth factor (PDGF). Previously, Tranquillo and
Murray (1992), in an extension of (1)-(6), assumed a static distribution for the chemical species.
To make the description more realistic, Olsen et al. (1995) incorporated a time-dependent rep-
resentation. Additionally, Olsen and colleagues included collagen synthesis and degradation.
Olsen et al. (1995) was able to predict plastic deformation (permanent wound contraction), but
only in the absence of collagen kinetics. However, it is now known that matrix turnover is ini-
tially rapid, implying that collagen kinetics should not be neglected. Hence, further modelling
is required to generate plastic deformation.
The description developed by Tranquillo and Murray (1992) used a purely viscoelastic formula-
tion for the mechanics. Consequently, the system returns to its original state unless a nonhomo-
geneous spatial distribution of chemical mediator is assumed. With this in mind, Cook (1995)
extended Tranquillo and Murray’s work by developing a more realistic representation of tissue
mechanics that accounts for the structure of a changing, anisotropic ECM. In so doing, Cook
was the first to address tissue growth and remodelling and their associated effects upon tissue
mechanics. These effects are also considered in Murphy et al. (2011), who also incorporated
direct stress coupling between the cells and their mechanical environment.
When cultured under mechanical strain and/or on a stiff substrate, fibroblasts develop actin
stress fibres (Grinnell, 2000; Tomasek et al., 2002; Grinnell, 2003; Desmouliere et al., 2005). In
this state, the cells are termed proto-myofibroblasts, and they exert more cell traction on the
ECM than fibroblasts and exhibit upregulated collagen synthesis. Under the action of TGFβ,
proto-myofibroblasts differentiate into myofibroblasts, which are distinguished by the presence
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of α-smooth muscle actin (α-SMA) (Hinz, 2007; Wells and Discher, 2008; Wipff and Hinz, 2008,
2009; Hinz, 2010). To our knowledge, Javierre et al. (2009) and Murphy et al. (2011) are
the only papers to present mathematical models for dermal wound healing that incorporate the
stress-dependency of fibroblast to myofibroblast differentiation. However, neither representation
considers the proto-myofibroblast stage, instead adopting a combined proto-myofibroblast and
myofibroblast population.
The model developed by Javierre et al. (2009) is an extension of the Olsen et al. (1995) model in
which PDGF is assumed to be the chemical involved in activating fibroblasts. While PDGF can
induce the formation of proto-myofibroblasts, it does not induce transformation to myofibrob-
lasts or expression of α-SMA (Tomasek et al., 2002). Moreover, Javierre et al. (2009) assume
that cell traction stress activates fibroblasts, but Hall (2009) found that, for consistency be-
tween the mathematical representation and experimental results, the stress component involved
in fibroblast activation is the elastic stress and not the cell traction stress. If fibroblast differen-
tiation is assumed to depend on cell traction stress then the greatest activation occurs outside
the lesion, i.e. in the unwounded tissue. This is not physiological, as the myofibroblast presence
is greatest within the wound space. In contrast, making differentiation depend on the elastic
stress would lead to higher rates of conversion within the wound space itself. Moreover, the cell
traction stress can be thought of as a convenient representation of what is actually a body force
acting on the tissue. By pulling on the tissue, each cell acts as a force dipole; the net effect of
these dipoles is a body force determined by the gradient of the cell traction stress. Thus, the
elastic stress is the real stress in the ECM, and it is most reasonable to expect that this is the
stress that cells will feel and to which they will respond.
Incorporating these observations into a model means that it is impossible to decouple the me-
chanics from the biology because there is two-way feedback between cellular behaviour and
mechanical stress. In the Olsen et al. (1995) and Tranquillo and Murray (1992) descriptions,
passive ECM-mediated advection was the only interaction between the cell and ECM behaviour
and the wound mechanics. However, since the velocity was generally small, advection could
be neglected without significantly altering the model predictions (Hall, 2009). Consequently,
the cellular and ECM components could essentially evolve independent of the mechanics. We
argue that this coupling is important in light of recent experimental results and so attempt
to resolve this issue by incorporating the stress-dependence in the activation of fibroblasts and
myofibroblast proliferation.
The model of Murphy et al. (2011) incorporated some of this feedback between the cells and
tissue mechanics. This representation extended the work of Olsen et al. (1995), Cook (1995)
and Hall (2009), employing a morphoelastic approach to representing the mechanical behaviour
instead of the traditional linear viscoelasticity. This model is more appropriate for the large
deformations observed in wound repair, but it neglected to develop a detailed approximation to
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the chemical kinetics and their associated interactions with cellular and extracellular aspects of
repair.
The wound healing model proposed by Dale et al. (1997) does not incorporate tissue mechanics,
but it contains the most detailed description of the chemical kinetics of the bioactive species in
a dermal wound. Here, we adopt a reduced version of the Dale et al. (1997) model, in spite of
the fact that this represents a simplification of the in-vivo kinetics. Additionally, we modify the
model to incorporate recent experimental results.
When comparing model predictions against experimental data, researchers developing mechanochem-
ical representations of dermal repair typically consider the wound contraction dynamics recorded
by McGrath and Simon (1983). However, the wound contraction data obtained by McGrath and
Simon (1983) are for rat dermal repair, and mechanochemical modellers are generally seeking
to justify a model for human dermal wound healing. Rat and human dermal wounds heal pri-
marily by different mechanisms. While rat wounds heal mainly by contraction, human dermal
wounds (while still experiencing contraction) heal primarily as a result of infilling. Thus, we
qualitatively compare our predictions against the observations of McGrath and Simon (1983),
but seek to ascertain the relevance of our model by comparing our predictions against the wound
contraction data obtained by Catty (1965) for human dermal repair.
The role of TGFβ is now considered to be critical to dermal repair but there are, as yet, no
mechanochemical models that consider TGFβ as the primary growth factor in dermal repair.
Additionally, none include the regulatory effects of collagenase on the collagen density. Here,
we incorporate TGFβ and collagenase into a simplified representation of chemical kinetics and
then couple this with a description of tissue mechanics and cellular dynamics. With regard to
cellular interactions, our model includes a novel representation of the fibroblast to myofibroblast
activation.
We develop our proposed model in Section 2 below and present the model results in Section
3. Our model predicts early retraction followed by contraction and late retraction. The results
are compared with two sets of experimental data on wound closure, that of Catty (1965) for
human wounds, and that of McGrath and Simon (1983) for rat dermal repair. We seek only to
obtain qualitative agreement with the McGrath and Simon data. Our analysis shows that the
model predicts all phases of wound repair (retraction, contraction, permanent contraction and
late retraction) for both situations.
2. Mathematical Model
We consider seven dependent variables in our model: fibroblast density (n), myofibroblast den-
sity (m), transforming growth factor-β concentration (β), platelet-derived growth factor concen-
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tration (P ), collagen density (ρ), collagenase density (z), ECM displacement (u) and velocity
(v). We assume that the wound is long and thin, and that it is much longer than it is deep. As
such, a one-dimensional representation is appropriate.
We assume that a small strain representation is valid and thus the velocity can be approximated
by the Eulerian time derivative of displacement:
v =
∂u
∂t
. (7)
2.1. Force Balance Equation
Following Tranquillo and Murray (1992), we neglect inertial forces and so the momentum con-
servation equation reduces to a mechanical force balance between the forces related to the
physico-chemical ECM properties (consisting of tethering to the underlying fascia, elastic and
viscous forces) and the cell-generated traction forces. We assume that the tethering force is
proportional to the local collagen concentration and tissue displacement. Together, this gives
the following force balance equation:
sρu =
∂
∂x
(
σ + µ
∂v
∂x
+ ψ
)
, (8)
where s is the tethering coefficient, µ is the tissue viscosity, and σ and ψ represent the elastic
and cell traction forces, respectively.
Since we are considering a linear viscoelastic framework, the elastic force is proportional to the
deformation gradient (Skalak et al., 1996). However, we further assume that variations in colla-
gen density will affect the elastic modulus (Ramtani et al., 2002; Ramtani, 2004). Specifically,
we will assume that the elastic modulus is directly proportional to the collagen density, with a
constant of proportionality, E. Thus, σ takes the form
σ = Eρ
∂u
∂x
. (9)
There are a number of possible expressions for cell traction. Following Tranquillo and Murray
(1992), we assume that cell traction forces depend upon the product of the cellular and collagen
densities. We also assume that fibroblasts and myofibroblasts contribute differently to cell
traction but we do not include any ‘social loafing’ terms. This gives
ψ = λρ(n+ ξm), (10)
where λ is a constant and ξ is the myofibroblast tractional stress relative to fibroblast tractional
stress. We note that Olsen et al. (1995) assume that myofibroblasts increase the cell traction
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generated by the fibroblasts, but that myofibroblasts do not work independently to enhance cell
traction. However, Tomasek et al. (2002) indicates that myofibroblasts work independently of
fibroblasts to effect contraction. Also we note that other expressions for cell traction could be
adopted in which ψ is no longer directly proportional to n, m or ρ (see Tranquillo and Murray,
1992, and Olsen et al., 1995). It is preferable to use the simplest form available for cell traction
consistent with experimental observations, and so we adopt the above expression.
2.2. Fibroblasts
We assume that the fibroblasts exhibit random motility (modelled by diffusion), PDGF-mediated
chemotaxis and experience ECM-mediated advection. TGFβ stimulates fibroblast proliferation
which, in the absence of other factors, is assumed to be logistic. Fibroblast to myofibroblast
transformation requires tension (represented by positive elastic stress) and the presence of active
TGFβ. Hence, we obtain
∂n
∂t
+
∂
∂x
(nv) =
∂
∂x
[
Dn
∂n
∂x
− χn
(aχ + P )2
∂P
∂x
]
+ (1 + anββ)n (r − θnn(n+m))− ασ+βn, (11)
where Dn is the fibroblast random motility coefficient, χ is the chemotactic coefficient, aχ
represents the half-maximal response, α is the fibroblast differentiation rate, σ+ represents the
positive elastic stress, anβ represents the upregulation of fibroblast proliferation in the presence
of TGFβ, r is the intrinsic fibroblast proliferation rate and θnn represents the reduction in
proliferation due to crowding.
Since there is insufficient experimental evidence to suggest otherwise, we assume that myofibrob-
lasts do not transform back to fibroblasts, but instead undergo apoptosis (Moulin et al., 2004;
Hinz, 2007; Farahani and Kloth, 2008). However, we note that Olsen et al. (1995) include the
reversion of myofibroblasts to fibroblasts. Moreover, we do not include a proto-myofibroblast
population, and instead consider a combined proto-myofibroblast and myofibroblast population,
which we simply refer to as myofibroblasts.
2.3. Myofibroblasts
Without evidence that myofibroblasts are actively motile, we assume that their transport is due
only to ECM-mediated advection. As long as the granulation tissue is under stress, myofibrob-
lasts will proliferate (Grinnell, 1994; Hinz, 2007). Hence, we follow Hall (2009) and assume
that myofibroblasts only proliferate under stress and that this growth is bounded. Finally,
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myofibroblasts undergo natural cell death. Together, these assumptions give
∂m
∂t
+
∂
∂x
(mv) = m
(
amσσ
+ (1 + amββ)− θm − θmm(n+m)
)
+ ασ+βn, (12)
where amβ represents the upregulation in myofibroblast proliferation under the action of TGFβ,
amσ is the intrinsic myofibroblast proliferation rate under tension, θm is the natural cell death
rate and θmm represents the decrease in proliferation due to crowding.
2.4. TGFβ
TGFβ diffuses and is passively advected by the ECM. This growth factor is produced by both
fibroblasts and myofibroblasts (Hinz, 2007; Wipff et al., 2007), with production inhibited by
the presence of TGFβ (Dale et al., 1996). We recognise that TGFβ is synthesized by cells in
a latent form, which is then activated by one of two mechanisms. These are the activation by
myofibroblasts from large latent complex stores attached to the ECM (Wipff et al., 2007; Wells
and Discher, 2008) and the cleavage of circulating latent TGFβ by collagenases (Dale et al.,
1996). For simplicity, we consider a combined latent and active TGFβ species. TGFβ also
undergoes natural decay. Incorporating all of these effects into a model, we obtain:
∂β
∂t
+
∂
∂x
(βv) = Dβ
∂2β
∂x2
+
aββ(n+ pim)
1 + bββ
+ aβmmρ+ aβzzβ − δββ, (13)
where Dβ is the TGFβ diffusivity, aβ characterizes the production rate of TGFβ by fibroblasts,
pi is the ratio of myofibroblast to fibroblast production of TGFβ, aβm is the activation rate of
TGFβ from matrix stores, aβz is the activation rate of latent TGFβ by collagenases and δβ is
the decay rate of TGFβ. We adopt a saturation form for the production of TGFβ, with bβ
related to the half-maximal rate of production.
2.5. PDGF
Macrophages and other cells produce PDGF, which we assume occurs at a constant rate, aP .
PDGF also experiences natural decay and depletion through endocytosis by both fibroblasts and
myofibroblasts, with myofibroblasts assumed to uptake the same amount of PDGF as fibroblasts.
Finally, PDGF diffuses and is advected by the ECM. Thus,
∂P
∂t
+
∂
∂x
(Pv) = Dp
∂2P
∂x2
+ aP − δPP − δPn(n+m)P, (14)
where DP is the PDGF diffusivity, δP represents natural decay and δnP denotes fibroblast and
myofibroblast-mediated PDGF depletion.
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2.6. Collagen
Collagen undergoes ECM-mediated advection and is synthesized by both cell types, with pro-
duction upregulated by the presence of TGFβ. Additionally, collagen is degraded by the action
of collagenases. Thus, we obtain
∂ρ
∂t
+
∂
∂x
(ρv) = k(n+ ηm)(1 + aρββ)− δρρz, (15)
where k characterizes the production rate of collagen by fibroblasts, η is the ratio of myofibroblast
to fibroblast collagen production, aρβ is a measure of the increase in synthesis due to the presence
of TGFβ and δρ is the degradation rate. Note that we refer to collagen and ECM interchangeably
throughout the rest of this paper, since dermal ECM consists mainly of collagen.
2.7. Collagenase
While several species of collagenase are involved in the wound healing process, we consider here
a general representation of these enzymes. Since collagenase binds to the local ECM, we assume
that diffusion is negligible and thus collagenase transport is only by ECM-mediated advection
(Dale et al., 1997). Both fibroblasts and myofibroblasts secrete collagenase in the presence of
collagen, with production of collagenase inhibited by the presence of active TGFβ (Wipff and
Hinz, 2009). Furthermore, collagenase undergoes natural decay. Putting this together, we have
∂z
∂t
+
∂
∂x
(zv) =
azρ(n+ ζm)
1 + bzβ
− δzz, (16)
where az characterizes the production rate of collagenase by cells in the presence of collagen,
ζ is the rate of myofibroblast collagenase synthesis relative to fibroblast collagenase synthesis,
bz measures the inhibition of collagenase synthesis due to the presence of TGFβ, and δz is the
collagenase decay rate.
We note that collagenase is secreted by cells in a latent form that is activated through proteolytic
cleavage. Dale et al. (1997) incorporate this feature into their model. However, for simplicity,
we have chosen to combine the latent and active forms of collagenase as a single species. We
also note that collagenases are a subset of the matrix metalloproteinases (MMPs) and that the
collagenase in this model could be identified with MMP-1. Both Chakraborti et al. (2003) and
Jenkins (2008) provide extensive reviews of MMPs in ECM.
2.8. Initial/Boundary Conditions and Non-Dimensionalization
The initial conditions of our model refer to the state of the wound at the onset of the proliferative
phase. At this stage, we take the wound to occupy −L < x < L, so that L represents the wound
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boundary. We assume:
1. Symmetry about x = 0, and so we can restrict ourselves to considering the domain where
x is positive;
2. x > L represents unwounded tissue;
3. The characteristic time scale of the model, T , is one day;
4. There are no fibroblasts within the wound space and they are at unwounded levels outside;
5. The initial myofibroblast density is zero everywhere;
6. Due to growth factor release in the inflammatory stage, TGFβ is present inside the wound
space, but not outside;
7. Within the wound, PDGF is initially at its steady state value in the case of no fibroblasts,
while outside the lesion PDGF takes its steady state value appropriate for the situation in
which fibroblasts are present;
8. There is a small amount of collagen in the wound space initially, while unwounded levels
prevail outside; and
9. Collagenase is only produced in the presence of collagen, and thus that there is no colla-
genase in the wound initially and that it is at unwounded levels outside.
To avoid discontinuities which can give rise to numerical instabilities when solving the PDE
system we approximate these piecewise conditions using tanh functions (see Appendix B for
details).
Immediately following injury, there is an almost instantaneous retraction of the wound boundary
(see for example Billingham and Medawar, 1955, Catty, 1965). Indeed, the unwounded dermis
surrounding the wound has an elastic tension that tends to draw the wound edges apart (Watts,
1960; Kennedy and Cliff, 1979). Therefore, the initial displacement is not zero throughout the
domain, but is rather found by demanding the force balance expression (8) hold. Since this
initial retraction is driven by elastic tension, we neglect viscosity when determining the initial
displacement.
The symmetry around x = 0 implies zero flux conditions for all species other than displacement
and velocity, which must necessarily be zero at the wound centre. For numerical purposes all
species are assumed to take on their unwounded values at the right-hand boundary (far away
from the wound site),
n(xRH , t) = nU , m(xRH , t) = 0, β(xRH , t) = βU , P (xRH , t) = PU ,
ρ(xRH , t) = ρU , z(xRH , t) = zU , u(xRH , t) = 0,
where xRH is the position of the right hand boundary and xRH  L, and nU , βU , PU , ρU and zU
represent the unwounded densities of fibroblasts, TGFβ, collagen and collagenases, respectively.
11
The system was non-dimensionalized (see Appendix A), discretised using finite difference approx-
imations in space and solved numerically using MATLAB’s inbuilt routine, ode45. We consider
a grid size of 401 and a computational domain of 10 semi-wound lengths; this ensures that the
right hand boundary is far enough from the wound site so as not to affect the solution within
the wound. Grid independent results are obtained providing the grid size exceeds 301 nodes.
Advective terms are determined by solving the tri-diagonal system obtained by discretising the
force balance expression, (8), with displacement found by subsequently using (7).
2.9. Parameter Values
Almost all parameter values have been estimated from experimental results or taken from previ-
ous models of dermal repair. Table 1 contains the dimensional values of the parameters together
with the source of the data; if a given parameter has been estimated in this work, this is indicated
by TW. The sensitivity analysis shows our model to be quite robust to significant variations in
a number of parameter values. For a full discussion on parameter estimation see Appendix C.
3. Results
Figures 1-5 show the results obtained from the numerical solution of the system of governing
equations and we now discuss these in detail.
3.1. Fibroblasts
Initially, there are no fibroblasts inside the wound space and they are at unwounded levels
outside. While fibroblasts are recruited from the surrounding dermis, proliferation is the primary
mode by which the fibroblast population within the wound space is restored. There is significant
conversion of fibroblasts to myofibroblasts over the first fortnight of repair, which accounts for the
unusual shape of the fibroblast distribution. Indeed, the mechanical stimulation of fibroblast
activation impedes the restoration of the fibroblast density within the wound space through
modulation to myofibroblasts. Nonetheless, by day 30 the fibroblast density across the domain
has essentially been restored to undamaged tissue values. We note that varying the chemotactic
coefficient has little impact on the model predictions.
3.2. Myofibroblasts
Initially, there are no myofibroblasts in the system. Fibroblasts are activated to become myofi-
broblasts under the action of elastic stress and TGFβ, and, for this parameter set, this conversion
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Parameter Range Reference
Dn, Fibroblast random motility Dn ≈ O(10−3)cm2/day Sillman et al. (2003)
χ, Chemotaxis χ ≈ 0.03ng/cm.day Haugh (2006), TW
aχ, Half-maximal response aχ ≈ 2ng/cm3 Olsen et al. (1995)
r, Fibroblast proliferation 0.832 < r < 0.924/day Ghosh et al. (2007)
anβ , Enhancement of fibroblast anβ ≈ 2/β0 Strutz et al. (2001)proliferation by TGFβ
θnn, 1/Fibroblast carry capacity θnn ≈ 10−6cells Vande Berg et al. (1989)
α, Fibroblast activation
r ≈ 0.0108/day.(ng/mL) Desmouliere et al. (1993)
to myofibroblasts
amσ, Myofibroblast proliferation amσ ≈ 0.5r Vande Berg et al. (1989)
amβ , Enhancement of myofibroblast amβ ≈ anβ Olsen et al. (1995)proliferation by TGFβ
θm, Myofibroblast apoptosis θm ≈ 0.9/day Olsen et al. (1995)
θmm, 1/Myofibroblast carrying capacity θmm ≈ 2θnn Masur et al. (1996)
Dβ , TGFβ diffusivity Dβ ≈ 0.0254cm2/day Stokes-Einstein Formula
aβ , TGFβ synthesis by fibroblasts aβ ≈ 0.125× 10−6ng/cell.day Wang et al. (2000)
pi, TGFβ synthesis by myofibroblasts
pi ≈ 2 Kim and Friedman (2009)
relative to fibroblasts
bβ , Inhibition of TGFβ synthesis bβ ≈ 5/β0 Dale et al. (1995)
aβm, TGFβ activation by myofibroblasts aβm ≈ 4.35× 10−9mL.day/cell Order of magnitude estimate, TW
aβz, TGFβ activation by proteolytic aβz ≈ 0.0014mL/ng.day Order of magnitude estimate, TWcleavage
δβ , TGFβ decay b ≈ 0.354/day Yang et al. (1999)
DP , PDGF diffusion coefficient DP ≈ 2.88× 10−3cm2/day Haugh (2006)
aP , PDGF production aP ≈ 24ng/cm3.day Monine and Haugh (2008), TW
δP , PDGF degradation δP ≈ 2.4/day Haugh (2006)
δPn, fibroblast-mediated PDGF δPn ≈ 2.4× 10−5/cell.day Haugh (2006), TW
depletion Monine and Haugh (2008)
k, Collagen production k ≈ 1.75pg/cell.day Bahar et al. (2004)
η, Relative collagen production
η ≈ 2 Moulin et al. (1998),
by myofibroblasts Olsen et al. (1995)
aρβ , Enhancing of collagen production aρβ ≈ 2/β0 Eickelberg et al. (1999)by TGFβ
δρ, Collagen degradation δρ ≈ 0.3k Aumailley et al. (1982)
az, Collagenase production az ≈ 3.37× 10−9ng/cell.day Oono et al. (2002),Dale et al. (1996), TW
ζ, Relative collagenase production
ζ ≈ 2 TW
by myofibroblasts
bz, Inhibition of collagenase production bz ≈ 3/β0 Overall et al. (1991)by TGFβ
δz, Collagenase decay δz ≈ 0.3616/day Overall et al. (1991)
s, Tethering coefficient s ≈ 1 Olsen et al. (1995)
µ, Viscosity µ ≈ O(10) Olsen et al. (1995)
Y , Elastic modulus 10 < Y < 300N
Silver et al. (2001),
Genzer and Groenewold (2006)
τ , Fibroblast cell traction 1 < τ < 3µN/cell
Wrobel et al. (2002),
Fray et al. (1998)
ξ, Ratio of myofibroblast to
ξ ≈ 2 Wrobel et al. (2002)
fibroblast cell traction
β0, Initial TGFβ concentration β0 ≈ 275ng/mL Yang et al. (1999)
Table 1: Table of parameters, which unless otherwise specified, are used for all simulations. TW
refers to parameters that were estimated during this work. The determination of all parameter
values is discussed in Appendix C.
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Figure 1: Model predictions for the fibroblast and myofibroblast densities. Black solid curves represent
the initial condition of each species. Arrows indicate the direction of increasing time, with each curve
representing an increment in time of 6 days out to 30 days. The computational domain is ten semi-wound
lengths, so that 0 < x < 10. In order to show behaviour in the wound more clearly, only the domain
0 < x < 4 is shown. Parameter values are given by Dn = 0.001, χ = 0.003, aχ = 0.2 α = 3, anβ = 2,
r = 0.832, amβ = 2, amσ = 0.42, θm = 0.9, θmm = 1.64, Dβ = 0.025, aβ = 0.1, η = 2, bb = 5, aβz = 0.25,
aβm = 0.21, δβ = 0.35, DP = 0.0029, aP = 2.4, δP = 2.4, δPn = 20, κ = 0.1, pi = 2, aρβ = 2, ω = 0.2,
ζ = 2, bz = 5, s = 1, µ = 20, E = 10, λ = 2.2, ξ = 2.
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is found to be the primary source of myofibroblasts. Differentiation of fibroblasts generates a
population of myofibroblasts within the wound domain, which proliferate and generate stress.
Thus, myofibroblasts contribute to both wound contraction and further fibroblast activation.
Fibroblasts continue to transform to myofibroblasts, with the greatest density of myofibroblasts
occurring where the elastic stress is highest. There is a small level of myofibroblast activation
predicted outside the wound due to small elastic stresses and the presence of a small concentra-
tion of TGFβ there. At long time, both the elastic stress and TGFβ tend to zero, and so the
myofibroblast density tends to zero also (results not shown).
0 0.5 1 1.5 2 2.5 3 3.5 4
0
0.2
0.4
0.6
0.8
1
Distance
β
(x
,t
)
0 0.5 1 1.5 2 2.5 3 3.5 4
0
0.2
0.4
0.6
0.8
1
Distance
P
(x
,t
)
Figure 2: Model predictions for the TGFβ and PDGF concentration. Black solid curves represent
the initial condition of each species. Arrows indicate the direction of increasing time, with each curve
representing an increment in time of 6 days out to 30 days. Parameter values are the same as Figure 1.
3.3. Transforming Growth Factor β
TGFβ appears early in the wound healing process as a result of the inflammatory cascade. Since
there is no active TGFβ in unwounded dermis, the TGFβ concentration is initially zero outside
the wound space (see Figure 2). The concentration of TGFβ within the wound is gradually
depleted through natural decay. However, both fibroblasts and myofibroblasts produce TGFβ
15
and it can be activated through cleavage by collagenase and from latent stores in the matrix
by myofibroblasts. As a result, the decay of TGFβ is quickly stemmed, which explains why it
is still present at day 30, and why there is an increase in TGFβ around the wound boundary
for early times. At later times, the TGFβ concentration tends to zero throughout. We note
that our expression for myofibroblast activation of TGFβ from local matrix stores assumes that
fibroblasts and myofibroblasts bind more TGFβ to the ECM than can be activated when the
myofibroblasts contract the collagen fibers. Hence it is assumed that there is always a supply of
TGFβ attached to the matrix available for activation, which may or may not be accurate.
3.4. PDGF
Platelets release huge quantities of PDGF early in repair, yielding the significantly higher con-
centration of PDGF inside the wound initially. As fibroblasts repopulate the wound space,
fibroblast-mediated depletion of PDGF occurs until the PDGF concentration attains unwounded
levels within the lesion.
3.5. Collagen
Initially we assume that there is a low density of collagen within the wound while the density is
at unwounded levels outside. Synthesis of collagen by both fibroblasts and myofibroblasts is the
primary source of collagen. The wound is largely healed as a result of infilling, consistent with
experiments on human dermal repair (Catty, 1965). Collagen production by cells is upregulated
by the presence of TGFβ. This fact, combined with the near-unwounded levels of fibroblasts
and the high density of myofibroblasts, gives rise to excess collagen within the wound space; as
we see, the collagen profile is very similar to the TGFβ profile. While not shown in Figure 3,
remodelling by the fibroblasts at later times ensures that the collagen density ultimately tends
to unwounded levels throughout the domain.
3.6. Collagenase
It is assumed that there is no collagenase within the wound initially, but that the collagenase is
at unwounded levels outside. The collagenase concentration inside the lesion decreases at early
times, which can be attributed to the large early retraction. As the cells synthesize collagenase,
the production is inhibited by the presence of TGFβ, and collagenase secretion is lowest at the
wound centre where the TGFβ concentration is highest. Collagenase levels eventually tend to
unwounded levels. Since collagenase is non-zero at steady state, this implies that there is a
balance reached between collagenase production and degradation at steady state. Furthermore,
this suggests that there is continuous turnover of ECM in unwounded tissue, which is consistent
with clinical observations (Roberts et al., 1990).
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Figure 3: Model predictions for the collagen density, collagenase concentration and collagen displace-
ment. Black solid curves represent the initial condition of each species.Arrows indicate the direction of
increasing time, with each curve representing an increment in time of 6 days out to 30 days. It should be
noted, however, that u(x, t) increases during the first 6 days. Parameter values are the same as Figure 1.
We note that the computational domain is ten semi-wound lengths, such that 0 < x < 10, and that the
displacement, u, does tend to zero at the right hand boundary.
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3.7. Wound Boundary
The current position of the wound boundary can be obtained by finding the point x, where the
dimensionless displacement satisfies
xwb = 1 + u(xwb, t). (17)
Thus, xwb represents the material point that was located at x = 1 when t = 0. The movement
of the wound boundary is represented by the black curves in Figure 4.
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(a) Short time course showing prediction curve with first 16 days worth of data.
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(b) Long time course showing prediction curve against the full dataset.
Figure 4: The wound boundary prediction from our model is the black curve. Two series of data for
human wound closure were obtained from Catty (1965). Series A and B correspond to the red and blue
points respectively. The daily collection of wound boundary data ceased at day 16 post wounding. One
further measurement was made at 6 months. Parameter values are the same as Figure 1.
Figures 4a and 4b show the comparison between our predicted curve and the data obtained
by Catty (1965) for human wounds. Our model predicts the large initial retraction, and slow
contraction of the wound, agreeing well with the data. However, our model does not predict
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Figure 5: The wound boundary prediction from our model is the black curve, and has been scaled respec-
tive to the initial wound size. Data showing the contractile phases of wound closure were obtained from
McGrath and Simon (1983) for circular (•), small square (+) and large square (×) wounds respectively.
Parameter values are the same as Figure 1.
an initial scaled wound boundary position of unity. This is because our model begins after
the almost-instantaneous retraction that occurs following injury. In addition, whilst our model
does predict a small late retraction, we did not observe the large late retraction seen by Catty.
Apart from these few data points however, good agreement is seen between the data of Catty
(1965) and our prediction curves. This is especially true when examining the early expansion
and contraction measurements.
Table 2 gives the values for expansion (or retraction), contraction and late retraction observed
by both Catty and colleagues and our simulation curve. We note that our model did not predict
the maximum retraction to occur at day 16, but rather at day 22. Hence, we give two “healed”
estimates: the predicted day 16 result and the value obtained at the maximum contraction (day
22). However, the day 16 and 22 predictions differ very little and both indicate that the majority
of contraction occurs during the first three weeks of wound repair. These predictions are very
similar to those obtained by Catty (1965), aside from the post 6-months column. This again
confirms that for the proliferative stage of wound repair that we are modelling, good agreement
is seen between the model predictions and the data.
We note from Table 2 that the expansion and healed values are comparable. With regard to the
amount of late retraction predicted by our model, we were not able to obtain the large retraction
observed by Catty (1965). However, the purpose of our model was to simulate the proliferative
phase of wound repair, and so it is really only appropriate for the first 30 days of wound repair;
during this time, the model compares well with the experimental data.
In Figure 5 we consider the same simulation curve, but in this case we compare our prediction of
wound closure qualitatively against the McGrath and Simon (1983) data for rat dermal repair.
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Series Actual Area Pre- Post- Healed Six
(sq. cm.) Excision Excision Months
A 1.01 1.000 1.316 1.041 1.123
B 1.07 1.000 1.343 0.960 1.139
Model - 1.000 1.281
Day 16 Max
0.999
0.995 0.973
Table 2: Data reproduced from Catty (1965) together with the corresponding predictions from
our model. The healed model value at day 16 corresponds to the point when Catty terminated
the daily measurements, while ‘max’ represents the predicted maximum contraction from the
model at day 22. Series A contained 11 patients, while Series B had 9 patients. Pre-excision
refers to the area to be removed from the patient, actual area indicates the area of tissue actually
excised, post-excision is the area of the wound after the retraction or expansion of the wound
following removal of the tissue, healed refers to the day 16 values while six months values refer
to the amount of retraction observed six months following wounding, as measured by Catty and
predicted by the model.
Rat wounds exhibit far greater contraction than do human dermal injuries. Consequently, we
scale the data from McGrath and Simon (1983) using
yscaled =
5
7
+
2
7
ydata, (18)
so that comparable contraction is observed in both the data and the model predictions. This
scaling is sensible as human wounds heal with almost a third the contraction observed in rat
dermal repair.
We see from the figure that the initial retraction, contraction, permanent contraction and late
retraction observed in the data of McGrath and Simon (1983) are all predicted by our model.
Hence, not only does our model correctly predict the closure of human dermal wounds, it re-
produces all the phenomena found in murine dermal wound closure. Therefore, we believe this
model represents a reasonable description of the closure of dermal wounds.
4. Discussion
Learning about how chemical mediators change the behaviour of cells is essential if we are to
understand successful wound healing and chronic wound healing. This paper develops a mathe-
matical model of wound healing that takes into account recent experimental observations about
two of the critical cell types in wounds: fibroblasts and their more contractile form, myofibrob-
lasts. The observation that the conversion from fibroblasts to myofibroblasts requires both the
presence of TGFβ and tissue tension at the cellular level can only be modelled if a mechanical
approach is taken. Here we have extended the models of Tranquillo-Murray and Olsen and
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coworkers to include this activation process. The parameters in the model equations have been
established from the published literature where possible and the model predictions obtained by
solving the governing set of partial differential equations numerically. The predictions have been
compared with two sets of experimental observations: Catty’s observations on humans (Catty,
1965) and Simon and McGrath’s experiments on rats (McGrath and Simon, 1983). In both
cases the model predictions are consistent with the experiments.
Our model predicts the large retraction and subsequent contraction seen during the first month
of human dermal repair, a phenomenon not considered in previous mechanochemical represen-
tations of wound healing. The large retraction is due to the absence of fibroblasts and collagen
within the wound space, and the contraction occurs following infilling as the fibroblasts and
myofibroblasts contract the newly formed collagen matrix.
Previous researchers have not addressed the manner in which TGFβ and tissue mechanics inform
the activation of fibroblasts to myofibroblasts. Our model predicts that it is the elimination of
TGFβ from the system, together with the reduction in local tension, that reduces the presence
of myofibroblasts towards the end of the proliferative phase.
Our model investigates the complex interactions between cells, TGFβ and collagenase in the
regulation of collagen expression. During the period in which the TGFβ concentration is high,
we found that collagen expression is heightened within the wound space. This can be attributed
to both the presence of myofibroblasts and to the increased production of collagen by both
fibroblasts and myofibroblasts in the presence of TGFβ. The myofibroblast density and TGFβ
concentration tend to zero, but remodelling of the collagen network by fibroblasts and collagenase
continues, so that the collagen density approaches healed levels across the wound space.
While this paper has concentrated on successful “normal” dermal wound healing, we see that
this modeling framework could be extended in a number of ways. Excessive wound contraction
in humans can be both disfiguring and can cause mobility problems if the contractures occur
over joints in the hands or at the elbow. These are often associated with severe burns and we
are exploring strategies to reduce contractures by increasing the death rate of myofibroblasts
and nullifying the effects of TGFβ. Another extension is to incorporate the role of oxygen in
the wound healing process. McGrath and Emery (1985) showed that the contraction in a rat
wound was slowed when angiogenesis (new blood vessel growth) was impeded. We intend to
couple the current system with a representation of angiogenesis to examine the combined effect
of inflammation, fibroplasia and angiogenesis in wound closure.
Wound geometry and depth are known to play a role in the rapidity of repair (Billingham and
Russell, 1956; McGrath and Simon, 1983). Thus, one could extend the current model to two
dimensions to investigate the impact of these phenomena on healing. Another possibility would
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be to analyse how repair is affected by wound debridement, in which the granulation tissue
and other constituents are removed. Alternatively, it would be possible to examine the effect
of addition or removal of TGFβ. Indeed, Ferguson and O’Kane (2004) found that addition
of different isoforms of TGFβ can improve or exacerbate repair. Therefore, one may wish to
distinguish between the TGFβ isoforms instead of a summary, consider a more general TGFβ
distribution.
As our model includes TGFβ, collagenase and collagen, it can be used to investigate wound heal-
ing pathologies, such as keloid development, where the interactions between these three species
are significant. In future work, we will examine the formation of keloids using an extension of
this model. Another type of pathological scarring that warrants attention is scar hypertrophy.
In the Aarabi et al. (2007) experiments in murine tissue, scar hypertrophy was elicited when the
wound was held open. In our model, the undamaged dermal tissue/wound boundary was free
to move. However, by restricting this assumption, our framework could be modified to model
this setup.
We see an important aspect of wound healing that has not been modelled in detail is the inter-
action between the epidermal cells that migrate into the wound and the cells of the underlying
dermis. While some early work has addressed this issue (see chapters 9 and 10 of Murray, 2003),
there is a considerable body of recent experimental literature that elucidates the cross-talk be-
tween these cell types. The framework in this paper could be extended to include an invading
epidermal layer although the mechanics of this interaction would need to be informed by further
experimental data.
In summary, our model has been able to simulate the course of human dermal repair using
carefully determined parameter values. This model incorporates a detailed representation of
cytokine kinetics coupled with the intricate interactions between the cellular, extracellular and
chemical species. We addressed the manner by which TGFβ and tissue mechanics cooperate to
activate fibroblasts to myofibroblasts. The results are consistent with experimental data, with
the wound boundary curve shown to ably predict the human wound contraction data of Catty
(1965) and the scaled rat contraction experiments of McGrath and Simon (1983), with all of the
essential features of wound contraction being well matched. Moreover, our model successfully
simulates the heterogeneous nature of the mechanical environment and could be extended to
explore the effects of elevated skin tension on hypertrophic scarring and other pathologies.
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Appendix A. Non-Dimensional Equations
Applying the following non-dimensionalization
Nˆ =
r
θnn
, Bˆ = β0, Zˆ
2 =
azkNˆ
2
δρδζ
, Rˆ =
kNˆ
δρZˆ
, Vˆ =
L
T
D¯n =
DnT
L2
, α¯ = αBT, a¯nβ = anβBˆ, a¯n = rT, a¯mσ = amσT,
a¯mβ = amβBˆ, θ¯m = θmT, θ¯mm = θmmNˆT, a¯β = aβNˆT, b¯β = bβBˆ,
D¯β =
DβT
L2
, η¯ = η, a¯βm =
aβmNˆRˆT
Bˆ
, a¯βz = aβzZˆT, δ¯β = δβT,
K¯ =
kNˆT
Rˆ
, a¯ρβ = aρβBˆ, ω¯ = δζT, b¯ζ = bζBˆ, s¯ = sL
2,
E¯ = E, µ¯ =
µ
RˆT
, λ¯ = λNˆ, ξ¯ = ξ, p¯i = pi,
ζ¯ = ζ, Pˆ = P0, χ¯ =
χT
L2Pˆ
, a¯χ =
aχ
Pˆ
, D¯P =
DPT
L2
,
a¯P =
aPT
Pˆ
, δ¯P = δPT, δ¯Pn = δPnTNˆ,
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and dropping bars, we obtain the following non-dimensional equations,
∂n
∂t
+
∂
∂x
(nv) =
∂
∂x
[
Dn
∂n
∂x
− χn
(aχ + P )2
∂P
∂x
]
+ r (1 + anββ)n (1− n−m)− ασ+βn, (A.1)
∂m
∂t
+
∂
∂x
(mv) = m
(
amσσ
+ (1 + amββ)− θm − θmm(n+m)
)
+ ασ+βn, (A.2)
∂β
∂t
+
∂
∂x
(βv) = Dβ
∂2β
∂x2
+
aββ(n+ pim)
1 + bββ
+ aβmmρ+ aβzzβ − δββ (A.3)
∂P
∂t
+
∂
∂x
(Pv) = Dp
∂2P
∂x2
+ aP − δPP − δPnnP, (A.4)
∂ρ
∂t
+
∂
∂x
(ρv) = κ ((n+ ηm)(1 + aρββ)− ρz) , (A.5)
∂z
∂t
+
∂
∂x
(zv) = ω
(
ρ(n+ ζm)
1 + bzβ
− z
)
, (A.6)
sρu =
∂
∂x
(
σ + µ
∂v
∂x
+ ψ
)
, (A.7)
σ = Eρ
∂u
∂x
, (A.8)
ψ = λρ(n+ ξm), (A.9)
v =
∂u
∂t
. (A.10)
Appendix B. Initial Conditions
The following represent the scaled initial conditions employed in this model
n(x, 0) =
1
2
{
1 + tan
(
x− L
n
)}
, (B.1)
m(x, 0) = 0, (B.2)
β(x, 0) =
1
2
{
1− tan
(
x− L
β
)}
, (B.3)
P (x, 0) =
1
2
{
(Pss + Pin) + (Pss − Pin)tan
(
x− L
ρ
)}
, (B.4)
ρ(x, 0) =
1
2
{
(1 + ρin) + (1− ρin)tan
(
x− L
ρ
)}
, (B.5)
z(x, 0) =
1
2
{
1 + tan
(
x− L
z
)}
, (B.6)
where n = 0.1, β = ρ = z = 0.4, controlling the steepness across the boundary, ρin = 0.1, the initial
scaled collagen density within the wound space, Pss is the steady-state value for PDGF in the presence
of fibroblasts, given by Pss = aP /(δP + δPnn), Pin = aP /δP , is the steady-state value for PDGF in the
absence of fibroblasts and L = 1, the scaled initial position of the wound boundary.
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Appendix C. Parameter Estimation
First, we estimate values for the scalings used to non-dimensionalize the variables:
L: A typical length scale for acute dermal wounds is 1cm.
T : A typical length scale for time is days. Hence, T = 1 day.
r: In Murphy et al. (2011) we estimate fibroblast proliferation to be r = 0.832/day.
θ−1nn : The carrying capacity of fibroblasts is known to be approximately 10
6cells/mL (Vande Berg et al.,
1989). Hence, we take θ−1nn = 10
6cells/mL.
k/δρ: It is known that 30% of newly synthesized collagen is degraded (Aumailley et al., 1982). Hence, δρ =
0.3k, such that k/δρ = 3.33. Bahar et al. (2004) estimates a collagen production rate of 1.75pg/cell.day.
β0: Yang et al. (1999) found the initial concentration of TGFβ in the wound to be 275ng/mL. Hence, we
take β0 = 275ng/mL.
P0: Olsen et al. (1995) states that PDGF is stored in platelets at concentrations of approximately
15− 50ng/mL. Olsen et al. (1995), Haugh (2006) and Schugart et al. (2008) all propose an initial PDGF
concentraiton of P0 = 10ng/mL, which we adopt.
We can now apply the following non-dimensionalization.
x¯ =
x
L
, t¯ =
t
T
, n¯ =
n
Nˆ
, m¯ =
m
Nˆ
, P¯ =
P
P0
,
ρ¯ =
ρ
Rˆ
, z¯ =
z
Zˆ
, βˆ =
β
β0
u¯ =
u
L
, v¯ =
Tv
L
,
The values for the remaining dimensional parameters are as follows. app Dn: Experiments by Sillman
et al. (2003) found that fibroblasts derived from normal human dermal wounds migrate at an average
velocity of 0.23 − 0.36µm/min. This gives a range for the minimum wavespeed of 0.00033 < Dn <
0.001cm2/day. We choose the upper limit of Dn = 0.001cm
2/day.
χ: Olsen et al. (1995) recognized that the chemotactic coefficient should predominate over the random
diffusive flux. In the absence of quantitative studies, Haugh (2006) and Monine and Haugh (2008)
propose that the chemotactic coefficient is three times the magnitude of the diffusivity. We chose a value
for Dn = 0.001cm
2/day, and controlling for the PDGF density (P0 = 10ng/mL), this gives a chemotaxis
coefficient of χ = 0.03ng/cm.day.
aχ: Olsen et al. (1995) notes that experimental data suggests that the half-maximal response of fibroblasts
to PDGF-mediated chemotaxis occurs at a concentration of 2ng/mL. Thus, we take aχ = 2ng/mL.
anβ : Strutz et al. (2001) found TGFβ to increase fibroblast proliferation by 2 − 3 times. Hence, we
assume that anβ = 2/β0.
α: Desmouliere et al. (1993) found that culturing fibroblasts in the presence of TGFβ increased the
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percentage of cells expressing α-SMA from 7.5% to 45.3%, representing an activation of 37.8% of fibrob-
lasts, and is consistent with other estimates (Masur et al., 1996; Moulin et al., 1996). This experiment
occurred over a one week period, with a TGFβ dose of 5−10ng/mL. This gives a range for the activation
of 0.0054 < α < 0.0108/day.(ng/mL). We choose the upper limit of α = 0.0108/day.(ng/mL).
amσ: The myofibroblast growth rate is lower than that of normal dermal fibroblasts, with myofibroblast
growth approximately 50% that of fibroblasts (Vande Berg et al., 1989). Thus, we take the myofibroblast
proliferation to be half that of fibroblasts, such that amσ = 0.5r.
amβ : We assume that myofibroblasts experience the same increase in proliferation due to TGFβ as
fibroblasts. Hence, amβ = anβ .
θm: The doubling time of fibroblasts is approximately 18 hours (Olsen et al., 1995). We assume that the
doubling time of myofibroblasts is the same as that for fibroblasts. Hence, this gives a natural cell death
rate for the myofibroblasts of θm ≈ 0.90.
θmm: As myofibroblasts are roughly twice the size of fibroblasts (Masur et al., 1996), we assume that
myofibroblasts have half the carrying capacity of fibroblasts, i.e., θmm = 2θnn = (0.5× 106)−1.
Dβ : Using known estimates of the molecular weight of epidermal growth factor (EGF) and TGFβ (Cell
Signaling Technology, 2010) and the diffusivity of epidermal growth factor (Thorne et al., 2004), we
were able to determine the diffusivity of TGFβ using the Stokes-Einstein formula, such that Dβ ≈
0.0254cm2/day.
aβ : Experiments by Wang et al. (2000) give the range for TGFβ production by fibroblasts as 0.125 <
aβ < 0.525× 10−6ng/(cell.day). We choose the lower limit, such that aβ = 0.125× 10−6ng/(cell.day).
η, pi, ζ: On a percentage basis, myofibroblasts produce roughly twice the collagen that is synthesized
by fibroblasts (Kim and Friedman, 2009; Moulin et al., 1998; Olsen et al., 1995). Hence, we choose
η = 2. There is a similar trend for myofibroblast synthesis of TGFβ (see Kim and Friedman, 2009) and
based on these relations, we assume the same is true for myofibroblast production of collagenase. Hence,
pi = ζ = η = 2.
bβ : Using estimates from Dale et al. (1995), inhibition of TGFβ synthesis is assumed to be bβ = 5/β0.
aβz: Using order of magnitude approximation, we estimate the activation of TGFβ by collagenase to be
∼ O(0.1) when non-dimensionalized. Thus, aβz = 0.0014mL/ng.day.
aβm: We assume that the amount of TGFβ activated from matrix stores is of the same order of magnitude
as the amount of TGFβ activated by collagenase following non-dimensionalization, i.e., O(0.1). Hence,
we estimate the activation of TGFβ by myofibroblasts to be 4.37× 10−9mL.day/cell.
δβ : The TGFβ decay rate was estimated from the exponential phase of the data from Yang et al. (1999),
giving a rate of δβ ≈ 0.354/day.
DP : Haugh (2006) states that the diffusion coefficient for PDGF in aqueous solution is estimated at
10−6cm2/s (0.0864cm2/day), or twice the value taken by Olsen et al. (1995). However, Haugh (2006)
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then states that diffusion of cytokines in tissue is much slower than in solutions, and that the diffusion of
PDGF in the dermis is approximately one thirtieth of its value in solution. Thus, the diffusion coefficient
for PDGF is DP = 0.00288cm
2/day.
δP : Olsen et al. (1995), Haugh (2006) and Monine and Haugh (2008) all consider PDGF decay to be
O(1)/day. We use the value given by Haugh (2006) and Monine and Haugh (2008) of δP = 2.4/day.
aP : The range suggested by Olsen et al. (1995) for the production of PDGF (depending upon the cellular
density, which ranges from 104 − 106) is 4 − 400ng/cm3.day, while Haugh (2006) proposes limits of
4.8− 48ng/cm3/day, which we see encapsulates the lower end of the parameter range suggested by Olsen
et al. (1995). Both Haugh (2006) and Monine and Haugh (2008) use the value of aP = 24ng/cm
3.day
so that the production rate of PDGF balances the degradation rate in the absence of fibroblasts (where
aP = δPP0).
δPn: Haugh (2006) estimates the range for the fibroblast consumption of PDGF to be 2.4 < δPn < 48/day,
and proposes that a reasonable value for this parameter is 2.4/day, a value which Monine and Haugh
(2008) also adopts. After accounting for the cell density, we obtain an estimate for fibroblast PDGF
consumption of δPn = 2.4cm
3/cell.day.
aρβ : Eickelberg et al. (1999) found a 2− 3-fold increase in collagen expression by human lung fibroblasts
in the presence of TGFβ. We assume that TGFβ induces a similar increase in collagen production by
dermal fibroblasts. Hence, we estimate that aρβ = 2/β0.
az: Oono et al. (2002) estimates the collagenase accumulation over one day to be 5 − 35ng/mL. Using
this value, and the steady state values for collagen density (∼ 15µg/mg, Dale et al., 1996), fibroblasts
(r/θnn), collagenase (∼ 0.1ng/mL, determined from Dale et al., 1996) and recognizing that the velocity,
myofibroblast density and TGFβ concentration are zero, we may substitute into (16) and determine a
value for collagenase production. We estimate its value to be az = 3.37× 10−9ng/cell.day.
bz: Overall et al. (1991) found a reduction of 66− 75% of collagenase synthesis in the presence of TGFβ.
This gives an estimate of bz = 3/β0.
δz: Overall et al. (1991) estimate the half-life of MMP-2 as 46 hours. We assume that collagenase
(MMP-1) has the same half-life, giving a decay rate of 0.3616/day.
s: Following Tranquillo and Murray (1992), Olsen et al. (1995) and Javierre et al. (2009), we consider a
tethering coefficient of s = 1.
µ: We follow Olsen et al. (1995) and Javierre et al. (2009), and choose µ such that its non-dimensional
value is 20.
E: Estimates of E range from 1 − 300N/cm2 (Silver et al., 2001; Genzer and Groenewold, 2006). We
consider an area of approximately 1cm2, which gives a range of E of 10 < E < 300N. We use the lower
limit, such that E = 10N.
τ : In Murphy et al. (2011), we estimated a range for τ of 1 < τ < 3µN/cell. Hence, we consider a value
of τ = 2.65µN/cell, consistent with Fray et al. (1998) and Wrobel et al. (2002).
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ξ: Wrobel et al. (2002) found that myofibroblasts can apply up to twice the cell traction force generated
by fibroblasts. Hence, we choose ξ = 2.
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